nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Insomnia—Irinotecan—stomach cancer	0.00234	0.00291	CcSEcCtD
Roflumilast—Cardiac disorder—Docetaxel—stomach cancer	0.00234	0.00291	CcSEcCtD
Roflumilast—Dyspepsia—Irinotecan—stomach cancer	0.00228	0.00284	CcSEcCtD
Roflumilast—Immune system disorder—Docetaxel—stomach cancer	0.00228	0.00283	CcSEcCtD
Roflumilast—Mediastinal disorder—Docetaxel—stomach cancer	0.00227	0.00282	CcSEcCtD
Roflumilast—Cardiac disorder—Capecitabine—stomach cancer	0.00226	0.00282	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00226	0.00281	CcSEcCtD
Roflumilast—Decreased appetite—Irinotecan—stomach cancer	0.00225	0.0028	CcSEcCtD
Roflumilast—Insomnia—Fluorouracil—stomach cancer	0.00224	0.00279	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00224	0.00278	CcSEcCtD
Roflumilast—Fatigue—Irinotecan—stomach cancer	0.00223	0.00278	CcSEcCtD
Roflumilast—Constipation—Irinotecan—stomach cancer	0.00221	0.00275	CcSEcCtD
Roflumilast—Mental disorder—Docetaxel—stomach cancer	0.00221	0.00275	CcSEcCtD
Roflumilast—Immune system disorder—Capecitabine—stomach cancer	0.0022	0.00274	CcSEcCtD
Roflumilast—Mediastinal disorder—Capecitabine—stomach cancer	0.0022	0.00274	CcSEcCtD
Roflumilast—Malnutrition—Docetaxel—stomach cancer	0.00219	0.00273	CcSEcCtD
Roflumilast—Dyspepsia—Fluorouracil—stomach cancer	0.00218	0.00272	CcSEcCtD
Roflumilast—Gastritis—Epirubicin—stomach cancer	0.00217	0.0027	CcSEcCtD
Roflumilast—Decreased appetite—Fluorouracil—stomach cancer	0.00216	0.00268	CcSEcCtD
Roflumilast—Dysgeusia—Docetaxel—stomach cancer	0.00215	0.00267	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00214	0.00266	CcSEcCtD
Roflumilast—Mental disorder—Capecitabine—stomach cancer	0.00214	0.00266	CcSEcCtD
Roflumilast—Feeling abnormal—Irinotecan—stomach cancer	0.00213	0.00265	CcSEcCtD
Roflumilast—Malnutrition—Capecitabine—stomach cancer	0.00212	0.00264	CcSEcCtD
Roflumilast—Influenza—Epirubicin—stomach cancer	0.00212	0.00264	CcSEcCtD
Roflumilast—Back pain—Docetaxel—stomach cancer	0.00212	0.00264	CcSEcCtD
Roflumilast—Gastrointestinal pain—Irinotecan—stomach cancer	0.00212	0.00263	CcSEcCtD
Roflumilast—Muscle spasms—Docetaxel—stomach cancer	0.00211	0.00262	CcSEcCtD
Roflumilast—Dysgeusia—Capecitabine—stomach cancer	0.00208	0.00259	CcSEcCtD
Roflumilast—Back pain—Capecitabine—stomach cancer	0.00205	0.00256	CcSEcCtD
Roflumilast—Abdominal pain—Irinotecan—stomach cancer	0.00205	0.00255	CcSEcCtD
Roflumilast—Feeling abnormal—Fluorouracil—stomach cancer	0.00204	0.00254	CcSEcCtD
Roflumilast—Muscle spasms—Capecitabine—stomach cancer	0.00204	0.00254	CcSEcCtD
Roflumilast—Pneumonia—Methotrexate—stomach cancer	0.00203	0.00253	CcSEcCtD
Roflumilast—Infestation NOS—Methotrexate—stomach cancer	0.00202	0.00252	CcSEcCtD
Roflumilast—Infestation—Methotrexate—stomach cancer	0.00202	0.00252	CcSEcCtD
Roflumilast—Depression—Methotrexate—stomach cancer	0.00202	0.00251	CcSEcCtD
Roflumilast—Gastritis—Doxorubicin—stomach cancer	0.00201	0.0025	CcSEcCtD
Roflumilast—Tremor—Capecitabine—stomach cancer	0.00199	0.00248	CcSEcCtD
Roflumilast—Ill-defined disorder—Capecitabine—stomach cancer	0.00197	0.00245	CcSEcCtD
Roflumilast—Urticaria—Fluorouracil—stomach cancer	0.00197	0.00245	CcSEcCtD
Roflumilast—Influenza—Doxorubicin—stomach cancer	0.00196	0.00244	CcSEcCtD
Roflumilast—Palpitations—Docetaxel—stomach cancer	0.00194	0.00241	CcSEcCtD
Roflumilast—Weight decreased—Epirubicin—stomach cancer	0.00192	0.00239	CcSEcCtD
Roflumilast—Malaise—Capecitabine—stomach cancer	0.00192	0.00238	CcSEcCtD
Roflumilast—Hepatobiliary disease—Methotrexate—stomach cancer	0.00191	0.00238	CcSEcCtD
Roflumilast—Vertigo—Capecitabine—stomach cancer	0.00191	0.00237	CcSEcCtD
Roflumilast—Hypersensitivity—Irinotecan—stomach cancer	0.00191	0.00237	CcSEcCtD
Roflumilast—Pneumonia—Epirubicin—stomach cancer	0.0019	0.00237	CcSEcCtD
Roflumilast—Infestation NOS—Epirubicin—stomach cancer	0.00189	0.00236	CcSEcCtD
Roflumilast—Infestation—Epirubicin—stomach cancer	0.00189	0.00236	CcSEcCtD
Roflumilast—Palpitations—Capecitabine—stomach cancer	0.00188	0.00233	CcSEcCtD
Roflumilast—Myalgia—Docetaxel—stomach cancer	0.00187	0.00232	CcSEcCtD
Roflumilast—Asthenia—Irinotecan—stomach cancer	0.00186	0.00231	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00185	0.00231	CcSEcCtD
Roflumilast—Urinary tract infection—Epirubicin—stomach cancer	0.00184	0.00229	CcSEcCtD
Roflumilast—Hypersensitivity—Fluorouracil—stomach cancer	0.00183	0.00227	CcSEcCtD
Roflumilast—Myalgia—Capecitabine—stomach cancer	0.00181	0.00225	CcSEcCtD
Roflumilast—Anxiety—Capecitabine—stomach cancer	0.0018	0.00224	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.0018	0.00223	CcSEcCtD
Roflumilast—Hepatobiliary disease—Epirubicin—stomach cancer	0.00179	0.00223	CcSEcCtD
Roflumilast—Discomfort—Capecitabine—stomach cancer	0.00179	0.00222	CcSEcCtD
Roflumilast—Infection—Docetaxel—stomach cancer	0.00178	0.00221	CcSEcCtD
Roflumilast—Weight decreased—Doxorubicin—stomach cancer	0.00178	0.00221	CcSEcCtD
Roflumilast—Sinusitis—Epirubicin—stomach cancer	0.00178	0.00221	CcSEcCtD
Roflumilast—Diarrhoea—Irinotecan—stomach cancer	0.00177	0.0022	CcSEcCtD
Roflumilast—Pneumonia—Doxorubicin—stomach cancer	0.00176	0.00219	CcSEcCtD
Roflumilast—Nervous system disorder—Docetaxel—stomach cancer	0.00176	0.00218	CcSEcCtD
Roflumilast—Infestation NOS—Doxorubicin—stomach cancer	0.00175	0.00218	CcSEcCtD
Roflumilast—Infestation—Doxorubicin—stomach cancer	0.00175	0.00218	CcSEcCtD
Roflumilast—Skin disorder—Docetaxel—stomach cancer	0.00174	0.00216	CcSEcCtD
Roflumilast—Infection—Capecitabine—stomach cancer	0.00172	0.00214	CcSEcCtD
Roflumilast—Dizziness—Irinotecan—stomach cancer	0.00171	0.00213	CcSEcCtD
Roflumilast—Rhinitis—Epirubicin—stomach cancer	0.0017	0.00212	CcSEcCtD
Roflumilast—Urinary tract infection—Doxorubicin—stomach cancer	0.0017	0.00212	CcSEcCtD
Roflumilast—Nervous system disorder—Capecitabine—stomach cancer	0.0017	0.00211	CcSEcCtD
Roflumilast—Diarrhoea—Fluorouracil—stomach cancer	0.0017	0.00211	CcSEcCtD
Roflumilast—Cardiac disorder—Methotrexate—stomach cancer	0.00169	0.0021	CcSEcCtD
Roflumilast—Skin disorder—Capecitabine—stomach cancer	0.00168	0.00209	CcSEcCtD
Roflumilast—Connective tissue disorder—Epirubicin—stomach cancer	0.00167	0.00208	CcSEcCtD
Roflumilast—Hepatobiliary disease—Doxorubicin—stomach cancer	0.00166	0.00206	CcSEcCtD
Roflumilast—Vomiting—Irinotecan—stomach cancer	0.00165	0.00205	CcSEcCtD
Roflumilast—Sinusitis—Doxorubicin—stomach cancer	0.00164	0.00204	CcSEcCtD
Roflumilast—Immune system disorder—Methotrexate—stomach cancer	0.00164	0.00204	CcSEcCtD
Roflumilast—Dizziness—Fluorouracil—stomach cancer	0.00164	0.00204	CcSEcCtD
Roflumilast—Mediastinal disorder—Methotrexate—stomach cancer	0.00164	0.00204	CcSEcCtD
Roflumilast—Rash—Irinotecan—stomach cancer	0.00163	0.00203	CcSEcCtD
Roflumilast—Dermatitis—Irinotecan—stomach cancer	0.00163	0.00203	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00163	0.00203	CcSEcCtD
Roflumilast—Headache—Irinotecan—stomach cancer	0.00162	0.00202	CcSEcCtD
Roflumilast—Insomnia—Docetaxel—stomach cancer	0.00162	0.00201	CcSEcCtD
Roflumilast—Mental disorder—Methotrexate—stomach cancer	0.00159	0.00198	CcSEcCtD
Roflumilast—Malnutrition—Methotrexate—stomach cancer	0.00158	0.00197	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.00158	0.00196	CcSEcCtD
Roflumilast—Cardiac disorder—Epirubicin—stomach cancer	0.00158	0.00196	CcSEcCtD
Roflumilast—Vomiting—Fluorouracil—stomach cancer	0.00158	0.00196	CcSEcCtD
Roflumilast—Rhinitis—Doxorubicin—stomach cancer	0.00158	0.00196	CcSEcCtD
Roflumilast—Dyspepsia—Docetaxel—stomach cancer	0.00158	0.00196	CcSEcCtD
Roflumilast—Insomnia—Capecitabine—stomach cancer	0.00157	0.00195	CcSEcCtD
Roflumilast—Rash—Fluorouracil—stomach cancer	0.00156	0.00195	CcSEcCtD
Roflumilast—Dermatitis—Fluorouracil—stomach cancer	0.00156	0.00194	CcSEcCtD
Roflumilast—Decreased appetite—Docetaxel—stomach cancer	0.00156	0.00194	CcSEcCtD
Roflumilast—Headache—Fluorouracil—stomach cancer	0.00155	0.00193	CcSEcCtD
Roflumilast—Dysgeusia—Methotrexate—stomach cancer	0.00155	0.00193	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00155	0.00192	CcSEcCtD
Roflumilast—Connective tissue disorder—Doxorubicin—stomach cancer	0.00155	0.00192	CcSEcCtD
Roflumilast—Fatigue—Docetaxel—stomach cancer	0.00154	0.00192	CcSEcCtD
Roflumilast—Nausea—Irinotecan—stomach cancer	0.00154	0.00191	CcSEcCtD
Roflumilast—Immune system disorder—Epirubicin—stomach cancer	0.00154	0.00191	CcSEcCtD
Roflumilast—Mediastinal disorder—Epirubicin—stomach cancer	0.00153	0.00191	CcSEcCtD
Roflumilast—Constipation—Docetaxel—stomach cancer	0.00153	0.0019	CcSEcCtD
Roflumilast—Back pain—Methotrexate—stomach cancer	0.00153	0.0019	CcSEcCtD
Roflumilast—Dyspepsia—Capecitabine—stomach cancer	0.00153	0.0019	CcSEcCtD
Roflumilast—Decreased appetite—Capecitabine—stomach cancer	0.00151	0.00187	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Capecitabine—stomach cancer	0.0015	0.00186	CcSEcCtD
Roflumilast—Fatigue—Capecitabine—stomach cancer	0.00149	0.00186	CcSEcCtD
Roflumilast—Mental disorder—Epirubicin—stomach cancer	0.00149	0.00185	CcSEcCtD
Roflumilast—Constipation—Capecitabine—stomach cancer	0.00148	0.00184	CcSEcCtD
Roflumilast—Malnutrition—Epirubicin—stomach cancer	0.00148	0.00184	CcSEcCtD
Roflumilast—Feeling abnormal—Docetaxel—stomach cancer	0.00148	0.00184	CcSEcCtD
Roflumilast—Nausea—Fluorouracil—stomach cancer	0.00147	0.00183	CcSEcCtD
Roflumilast—Ill-defined disorder—Methotrexate—stomach cancer	0.00147	0.00182	CcSEcCtD
Roflumilast—Gastrointestinal pain—Docetaxel—stomach cancer	0.00146	0.00182	CcSEcCtD
Roflumilast—Cardiac disorder—Doxorubicin—stomach cancer	0.00146	0.00182	CcSEcCtD
Roflumilast—Tension—Epirubicin—stomach cancer	0.00145	0.00181	CcSEcCtD
Roflumilast—Dysgeusia—Epirubicin—stomach cancer	0.00145	0.0018	CcSEcCtD
Roflumilast—Nervousness—Epirubicin—stomach cancer	0.00144	0.00179	CcSEcCtD
Roflumilast—Back pain—Epirubicin—stomach cancer	0.00143	0.00178	CcSEcCtD
Roflumilast—Feeling abnormal—Capecitabine—stomach cancer	0.00143	0.00178	CcSEcCtD
Roflumilast—Malaise—Methotrexate—stomach cancer	0.00143	0.00177	CcSEcCtD
Roflumilast—Muscle spasms—Epirubicin—stomach cancer	0.00142	0.00177	CcSEcCtD
Roflumilast—Immune system disorder—Doxorubicin—stomach cancer	0.00142	0.00177	CcSEcCtD
Roflumilast—Vertigo—Methotrexate—stomach cancer	0.00142	0.00177	CcSEcCtD
Roflumilast—Gastrointestinal pain—Capecitabine—stomach cancer	0.00142	0.00176	CcSEcCtD
Roflumilast—Mediastinal disorder—Doxorubicin—stomach cancer	0.00142	0.00176	CcSEcCtD
Roflumilast—Abdominal pain—Docetaxel—stomach cancer	0.00142	0.00176	CcSEcCtD
Roflumilast—Mental disorder—Doxorubicin—stomach cancer	0.00138	0.00171	CcSEcCtD
Roflumilast—Urticaria—Capecitabine—stomach cancer	0.00138	0.00171	CcSEcCtD
Roflumilast—Ill-defined disorder—Epirubicin—stomach cancer	0.00137	0.00171	CcSEcCtD
Roflumilast—Abdominal pain—Capecitabine—stomach cancer	0.00137	0.0017	CcSEcCtD
Roflumilast—Malnutrition—Doxorubicin—stomach cancer	0.00137	0.0017	CcSEcCtD
Roflumilast—Myalgia—Methotrexate—stomach cancer	0.00135	0.00167	CcSEcCtD
Roflumilast—Tension—Doxorubicin—stomach cancer	0.00134	0.00167	CcSEcCtD
Roflumilast—Dysgeusia—Doxorubicin—stomach cancer	0.00134	0.00167	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00134	0.00166	CcSEcCtD
Roflumilast—Malaise—Epirubicin—stomach cancer	0.00133	0.00166	CcSEcCtD
Roflumilast—Discomfort—Methotrexate—stomach cancer	0.00133	0.00165	CcSEcCtD
Roflumilast—Nervousness—Doxorubicin—stomach cancer	0.00133	0.00165	CcSEcCtD
Roflumilast—Vertigo—Epirubicin—stomach cancer	0.00133	0.00165	CcSEcCtD
Roflumilast—Back pain—Doxorubicin—stomach cancer	0.00132	0.00165	CcSEcCtD
Roflumilast—Hypersensitivity—Docetaxel—stomach cancer	0.00132	0.00164	CcSEcCtD
Roflumilast—Muscle spasms—Doxorubicin—stomach cancer	0.00132	0.00164	CcSEcCtD
Roflumilast—Palpitations—Epirubicin—stomach cancer	0.00131	0.00163	CcSEcCtD
Roflumilast—Asthenia—Docetaxel—stomach cancer	0.00128	0.0016	CcSEcCtD
Roflumilast—Infection—Methotrexate—stomach cancer	0.00128	0.00159	CcSEcCtD
Roflumilast—Hypersensitivity—Capecitabine—stomach cancer	0.00128	0.00159	CcSEcCtD
Roflumilast—Ill-defined disorder—Doxorubicin—stomach cancer	0.00127	0.00158	CcSEcCtD
Roflumilast—Nervous system disorder—Methotrexate—stomach cancer	0.00127	0.00157	CcSEcCtD
Roflumilast—Myalgia—Epirubicin—stomach cancer	0.00126	0.00157	CcSEcCtD
Roflumilast—Anxiety—Epirubicin—stomach cancer	0.00126	0.00156	CcSEcCtD
Roflumilast—Skin disorder—Methotrexate—stomach cancer	0.00125	0.00156	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00125	0.00156	CcSEcCtD
Roflumilast—Discomfort—Epirubicin—stomach cancer	0.00124	0.00155	CcSEcCtD
Roflumilast—Asthenia—Capecitabine—stomach cancer	0.00124	0.00155	CcSEcCtD
Roflumilast—Malaise—Doxorubicin—stomach cancer	0.00123	0.00154	CcSEcCtD
Roflumilast—Vertigo—Doxorubicin—stomach cancer	0.00123	0.00153	CcSEcCtD
Roflumilast—Diarrhoea—Docetaxel—stomach cancer	0.00122	0.00152	CcSEcCtD
Roflumilast—Palpitations—Doxorubicin—stomach cancer	0.00121	0.0015	CcSEcCtD
Roflumilast—Infection—Epirubicin—stomach cancer	0.0012	0.00149	CcSEcCtD
Roflumilast—Diarrhoea—Capecitabine—stomach cancer	0.00119	0.00148	CcSEcCtD
Roflumilast—Nervous system disorder—Epirubicin—stomach cancer	0.00118	0.00147	CcSEcCtD
Roflumilast—Dizziness—Docetaxel—stomach cancer	0.00118	0.00147	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00118	0.00146	CcSEcCtD
Roflumilast—Skin disorder—Epirubicin—stomach cancer	0.00117	0.00146	CcSEcCtD
Roflumilast—Insomnia—Methotrexate—stomach cancer	0.00117	0.00145	CcSEcCtD
Roflumilast—Myalgia—Doxorubicin—stomach cancer	0.00117	0.00145	CcSEcCtD
Roflumilast—Anxiety—Doxorubicin—stomach cancer	0.00116	0.00144	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00116	0.00144	CcSEcCtD
Roflumilast—Discomfort—Doxorubicin—stomach cancer	0.00115	0.00143	CcSEcCtD
Roflumilast—Dizziness—Capecitabine—stomach cancer	0.00115	0.00143	CcSEcCtD
Roflumilast—Vomiting—Docetaxel—stomach cancer	0.00114	0.00142	CcSEcCtD
Roflumilast—Dyspepsia—Methotrexate—stomach cancer	0.00114	0.00141	CcSEcCtD
Roflumilast—Rash—Docetaxel—stomach cancer	0.00113	0.0014	CcSEcCtD
Roflumilast—Dermatitis—Docetaxel—stomach cancer	0.00113	0.0014	CcSEcCtD
Roflumilast—Decreased appetite—Methotrexate—stomach cancer	0.00112	0.0014	CcSEcCtD
Roflumilast—Headache—Docetaxel—stomach cancer	0.00112	0.0014	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00111	0.00139	CcSEcCtD
Roflumilast—Fatigue—Methotrexate—stomach cancer	0.00111	0.00138	CcSEcCtD
Roflumilast—Infection—Doxorubicin—stomach cancer	0.00111	0.00138	CcSEcCtD
Roflumilast—Vomiting—Capecitabine—stomach cancer	0.0011	0.00137	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.0011	0.00137	CcSEcCtD
Roflumilast—Nervous system disorder—Doxorubicin—stomach cancer	0.0011	0.00136	CcSEcCtD
Roflumilast—Rash—Capecitabine—stomach cancer	0.00109	0.00136	CcSEcCtD
Roflumilast—Insomnia—Epirubicin—stomach cancer	0.00109	0.00136	CcSEcCtD
Roflumilast—Dermatitis—Capecitabine—stomach cancer	0.00109	0.00136	CcSEcCtD
Roflumilast—Headache—Capecitabine—stomach cancer	0.00109	0.00135	CcSEcCtD
Roflumilast—Skin disorder—Doxorubicin—stomach cancer	0.00109	0.00135	CcSEcCtD
Roflumilast—Nausea—Docetaxel—stomach cancer	0.00106	0.00132	CcSEcCtD
Roflumilast—Feeling abnormal—Methotrexate—stomach cancer	0.00106	0.00132	CcSEcCtD
Roflumilast—Dyspepsia—Epirubicin—stomach cancer	0.00106	0.00132	CcSEcCtD
Roflumilast—Gastrointestinal pain—Methotrexate—stomach cancer	0.00106	0.00131	CcSEcCtD
Roflumilast—Decreased appetite—Epirubicin—stomach cancer	0.00105	0.00131	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00104	0.0013	CcSEcCtD
Roflumilast—Fatigue—Epirubicin—stomach cancer	0.00104	0.0013	CcSEcCtD
Roflumilast—Constipation—Epirubicin—stomach cancer	0.00103	0.00128	CcSEcCtD
Roflumilast—Nausea—Capecitabine—stomach cancer	0.00103	0.00128	CcSEcCtD
Roflumilast—Urticaria—Methotrexate—stomach cancer	0.00102	0.00128	CcSEcCtD
Roflumilast—Abdominal pain—Methotrexate—stomach cancer	0.00102	0.00127	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00102	0.00127	CcSEcCtD
Roflumilast—Insomnia—Doxorubicin—stomach cancer	0.00101	0.00126	CcSEcCtD
Roflumilast—Feeling abnormal—Epirubicin—stomach cancer	0.000995	0.00124	CcSEcCtD
Roflumilast—Gastrointestinal pain—Epirubicin—stomach cancer	0.000987	0.00123	CcSEcCtD
Roflumilast—Dyspepsia—Doxorubicin—stomach cancer	0.000983	0.00122	CcSEcCtD
Roflumilast—Decreased appetite—Doxorubicin—stomach cancer	0.000971	0.00121	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000964	0.0012	CcSEcCtD
Roflumilast—Fatigue—Doxorubicin—stomach cancer	0.000963	0.0012	CcSEcCtD
Roflumilast—Urticaria—Epirubicin—stomach cancer	0.000959	0.00119	CcSEcCtD
Roflumilast—Constipation—Doxorubicin—stomach cancer	0.000955	0.00119	CcSEcCtD
Roflumilast—Abdominal pain—Epirubicin—stomach cancer	0.000954	0.00119	CcSEcCtD
Roflumilast—Hypersensitivity—Methotrexate—stomach cancer	0.000951	0.00118	CcSEcCtD
Roflumilast—Asthenia—Methotrexate—stomach cancer	0.000926	0.00115	CcSEcCtD
Roflumilast—Feeling abnormal—Doxorubicin—stomach cancer	0.000921	0.00115	CcSEcCtD
Roflumilast—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000914	0.00114	CcSEcCtD
Roflumilast—Hypersensitivity—Epirubicin—stomach cancer	0.00089	0.00111	CcSEcCtD
Roflumilast—Urticaria—Doxorubicin—stomach cancer	0.000887	0.0011	CcSEcCtD
Roflumilast—Abdominal pain—Doxorubicin—stomach cancer	0.000883	0.0011	CcSEcCtD
Roflumilast—Diarrhoea—Methotrexate—stomach cancer	0.000883	0.0011	CcSEcCtD
Roflumilast—Asthenia—Epirubicin—stomach cancer	0.000866	0.00108	CcSEcCtD
Roflumilast—Dizziness—Methotrexate—stomach cancer	0.000853	0.00106	CcSEcCtD
Roflumilast—Diarrhoea—Epirubicin—stomach cancer	0.000826	0.00103	CcSEcCtD
Roflumilast—Hypersensitivity—Doxorubicin—stomach cancer	0.000823	0.00102	CcSEcCtD
Roflumilast—Vomiting—Methotrexate—stomach cancer	0.00082	0.00102	CcSEcCtD
Roflumilast—Rash—Methotrexate—stomach cancer	0.000813	0.00101	CcSEcCtD
Roflumilast—Dermatitis—Methotrexate—stomach cancer	0.000813	0.00101	CcSEcCtD
Roflumilast—Headache—Methotrexate—stomach cancer	0.000808	0.00101	CcSEcCtD
Roflumilast—Asthenia—Doxorubicin—stomach cancer	0.000802	0.000997	CcSEcCtD
Roflumilast—Dizziness—Epirubicin—stomach cancer	0.000798	0.000993	CcSEcCtD
Roflumilast—Vomiting—Epirubicin—stomach cancer	0.000768	0.000955	CcSEcCtD
Roflumilast—Nausea—Methotrexate—stomach cancer	0.000766	0.000953	CcSEcCtD
Roflumilast—Diarrhoea—Doxorubicin—stomach cancer	0.000764	0.000951	CcSEcCtD
Roflumilast—Rash—Epirubicin—stomach cancer	0.000761	0.000947	CcSEcCtD
Roflumilast—Dermatitis—Epirubicin—stomach cancer	0.000761	0.000946	CcSEcCtD
Roflumilast—Headache—Epirubicin—stomach cancer	0.000756	0.000941	CcSEcCtD
Roflumilast—Dizziness—Doxorubicin—stomach cancer	0.000739	0.000919	CcSEcCtD
Roflumilast—Nausea—Epirubicin—stomach cancer	0.000717	0.000892	CcSEcCtD
Roflumilast—Vomiting—Doxorubicin—stomach cancer	0.00071	0.000884	CcSEcCtD
Roflumilast—Rash—Doxorubicin—stomach cancer	0.000704	0.000876	CcSEcCtD
Roflumilast—Dermatitis—Doxorubicin—stomach cancer	0.000704	0.000876	CcSEcCtD
Roflumilast—Headache—Doxorubicin—stomach cancer	0.0007	0.000871	CcSEcCtD
Roflumilast—Nausea—Doxorubicin—stomach cancer	0.000664	0.000826	CcSEcCtD
Roflumilast—PDE4B—Signaling Pathways—GAST—stomach cancer	0.00027	0.00138	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RGS2—stomach cancer	0.00027	0.00138	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PPP2R1A—stomach cancer	0.000268	0.00136	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HSPB1—stomach cancer	0.000267	0.00136	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AGTR2—stomach cancer	0.000267	0.00136	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKAA1—stomach cancer	0.000266	0.00136	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—F2R—stomach cancer	0.000264	0.00135	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—BMP2—stomach cancer	0.000264	0.00135	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—AKR1C3—stomach cancer	0.00026	0.00132	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RBP4—stomach cancer	0.000257	0.00131	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HTR1A—stomach cancer	0.000257	0.00131	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGG—stomach cancer	0.000256	0.0013	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—ADRB2—stomach cancer	0.000253	0.00129	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PRKCB—stomach cancer	0.000249	0.00127	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ANXA1—stomach cancer	0.000248	0.00126	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PPP2R1A—stomach cancer	0.000248	0.00126	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKAA1—stomach cancer	0.000246	0.00126	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRB1—stomach cancer	0.00024	0.00123	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RBP4—stomach cancer	0.000238	0.00121	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HSPB1—stomach cancer	0.000232	0.00118	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AGTR2—stomach cancer	0.000232	0.00118	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—F2R—stomach cancer	0.00023	0.00117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—BMP2—stomach cancer	0.00023	0.00117	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RPS6—stomach cancer	0.00023	0.00117	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—AKR1C3—stomach cancer	0.000226	0.00115	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PRKCB—stomach cancer	0.000226	0.00115	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6ST—stomach cancer	0.000225	0.00115	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HTR1A—stomach cancer	0.000224	0.00114	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AGTR2—stomach cancer	0.000221	0.00113	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HSPB1—stomach cancer	0.000221	0.00113	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—F2R—stomach cancer	0.000219	0.00111	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—BMP2—stomach cancer	0.000219	0.00111	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PRKCB—stomach cancer	0.000217	0.0011	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ANXA1—stomach cancer	0.000216	0.0011	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—AKR1C3—stomach cancer	0.000215	0.0011	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HTR1A—stomach cancer	0.000213	0.00109	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HBEGF—stomach cancer	0.000211	0.00108	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRB1—stomach cancer	0.000209	0.00107	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PRKCB—stomach cancer	0.000206	0.00105	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ANXA1—stomach cancer	0.000206	0.00105	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AGTR2—stomach cancer	0.000205	0.00104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HSPB1—stomach cancer	0.000205	0.00104	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—BMP2—stomach cancer	0.000202	0.00103	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—F2R—stomach cancer	0.000202	0.00103	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6R—stomach cancer	0.000201	0.00102	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RPS6—stomach cancer	0.0002	0.00102	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—RHOA—stomach cancer	0.0002	0.00102	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRB1—stomach cancer	0.000199	0.00102	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—AKR1C3—stomach cancer	0.000199	0.00101	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HTR1A—stomach cancer	0.000197	0.001	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PRKCB—stomach cancer	0.000197	0.001	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6ST—stomach cancer	0.000196	0.000998	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ADRB2—stomach cancer	0.000195	0.000993	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PPP2R1A—stomach cancer	0.000191	0.000973	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PRKCB—stomach cancer	0.000191	0.000972	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RPS6—stomach cancer	0.00019	0.00097	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ANXA1—stomach cancer	0.00019	0.00097	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PRKCB—stomach cancer	0.000187	0.000954	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6ST—stomach cancer	0.000186	0.00095	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB1—stomach cancer	0.000184	0.000939	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HBEGF—stomach cancer	0.000184	0.000936	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—RHOA—stomach cancer	0.000181	0.000924	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SMAD4—stomach cancer	0.000177	0.000903	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RPS6—stomach cancer	0.000176	0.000897	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—CXCL8—stomach cancer	0.000175	0.000894	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HBEGF—stomach cancer	0.000175	0.000891	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6R—stomach cancer	0.000175	0.000891	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—RHOA—stomach cancer	0.000174	0.000886	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PRKCB—stomach cancer	0.000173	0.000883	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6ST—stomach cancer	0.000173	0.000879	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ADRB2—stomach cancer	0.00017	0.000864	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FYN—stomach cancer	0.000168	0.000857	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6R—stomach cancer	0.000166	0.000848	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PPP2R1A—stomach cancer	0.000166	0.000847	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—RHOA—stomach cancer	0.000165	0.000843	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HBEGF—stomach cancer	0.000162	0.000825	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ADRB2—stomach cancer	0.000161	0.000822	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—CXCL8—stomach cancer	0.000159	0.000811	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PPP2R1A—stomach cancer	0.000158	0.000806	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—FGFR2—stomach cancer	0.000158	0.000805	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—RHOA—stomach cancer	0.000158	0.000805	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SMAD4—stomach cancer	0.000154	0.000786	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6R—stomach cancer	0.000154	0.000785	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—RHOA—stomach cancer	0.000153	0.00078	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—CXCL8—stomach cancer	0.000153	0.000778	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—RHOA—stomach cancer	0.00015	0.000766	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ADRB2—stomach cancer	0.000149	0.000761	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SMAD4—stomach cancer	0.000147	0.000748	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FYN—stomach cancer	0.000146	0.000746	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PPP2R1A—stomach cancer	0.000146	0.000746	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—CXCL8—stomach cancer	0.000145	0.00074	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IRS2—stomach cancer	0.000145	0.000737	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CAV1—stomach cancer	0.00014	0.000715	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APOA1—stomach cancer	0.00014	0.000713	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FYN—stomach cancer	0.000139	0.000711	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—RHOA—stomach cancer	0.000139	0.000709	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—CXCL8—stomach cancer	0.000139	0.000706	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—FGFR2—stomach cancer	0.000137	0.000701	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SMAD4—stomach cancer	0.000136	0.000692	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—CXCL8—stomach cancer	0.000134	0.000685	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PRKCB—stomach cancer	0.000133	0.00068	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6ST—stomach cancer	0.000133	0.000678	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—CXCL8—stomach cancer	0.000132	0.000672	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—FGFR2—stomach cancer	0.000131	0.000667	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FYN—stomach cancer	0.000129	0.000657	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—APC—stomach cancer	0.000128	0.000651	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IRS2—stomach cancer	0.000126	0.000642	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—MAPK3—stomach cancer	0.000122	0.000623	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CAV1—stomach cancer	0.000122	0.000622	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—CXCL8—stomach cancer	0.000122	0.000622	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APOA1—stomach cancer	0.000122	0.000621	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—FGFR2—stomach cancer	0.000121	0.000617	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IRS2—stomach cancer	0.00012	0.000611	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6R—stomach cancer	0.000119	0.000604	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—MAPK1—stomach cancer	0.000116	0.000593	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—EGFR—stomach cancer	0.000116	0.000593	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CAV1—stomach cancer	0.000116	0.000592	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PRKCB—stomach cancer	0.000116	0.000592	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APOA1—stomach cancer	0.000116	0.000591	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6ST—stomach cancer	0.000116	0.00059	CbGpPWpGaD
Roflumilast—PDE4C—GPCR downstream signaling—PIK3CA—stomach cancer	0.000111	0.000567	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—APC—stomach cancer	0.000111	0.000567	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—SERPINE1—stomach cancer	0.000111	0.000566	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IRS2—stomach cancer	0.000111	0.000565	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PRKCB—stomach cancer	0.000111	0.000564	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6ST—stomach cancer	0.00011	0.000561	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—KRAS—stomach cancer	0.00011	0.00056	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CAV1—stomach cancer	0.000108	0.000548	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APOA1—stomach cancer	0.000107	0.000547	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—RHOA—stomach cancer	0.000107	0.000546	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—MAPK3—stomach cancer	0.000106	0.000543	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—NOS3—stomach cancer	0.000106	0.00054	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—APC—stomach cancer	0.000106	0.000539	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6R—stomach cancer	0.000103	0.000526	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PRKCB—stomach cancer	0.000102	0.000522	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6ST—stomach cancer	0.000102	0.000519	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—MAPK3—stomach cancer	0.000101	0.000517	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—MAPK1—stomach cancer	0.000101	0.000516	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—EGFR—stomach cancer	0.000101	0.000516	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—PIK3CA—stomach cancer	0.000101	0.000515	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—ERBB2—stomach cancer	9.92e-05	0.000505	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6R—stomach cancer	9.83e-05	0.000501	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—APC—stomach cancer	9.79e-05	0.000499	CbGpPWpGaD
Roflumilast—PDE4D—GPCR downstream signaling—PIK3CA—stomach cancer	9.68e-05	0.000493	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—SERPINE1—stomach cancer	9.67e-05	0.000493	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—MAPK1—stomach cancer	9.64e-05	0.000492	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—EGFR—stomach cancer	9.64e-05	0.000491	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—KRAS—stomach cancer	9.57e-05	0.000488	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CXCL8—stomach cancer	9.4e-05	0.000479	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—MAPK3—stomach cancer	9.38e-05	0.000478	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—HRAS—stomach cancer	9.34e-05	0.000476	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—RHOA—stomach cancer	9.33e-05	0.000475	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—NOS3—stomach cancer	9.23e-05	0.00047	CbGpPWpGaD
Roflumilast—PDE4A—GPCR downstream signaling—PIK3CA—stomach cancer	9.22e-05	0.00047	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—SERPINE1—stomach cancer	9.2e-05	0.000469	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDKN1B—stomach cancer	9.18e-05	0.000468	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—KRAS—stomach cancer	9.11e-05	0.000464	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6R—stomach cancer	9.09e-05	0.000463	CbGpPWpGaD
Roflumilast—PDE4C—Signaling by GPCR—IL6—stomach cancer	8.94e-05	0.000456	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—MAPK1—stomach cancer	8.92e-05	0.000455	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—EGFR—stomach cancer	8.92e-05	0.000455	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—RHOA—stomach cancer	8.88e-05	0.000452	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—PIK3CA—stomach cancer	8.79e-05	0.000448	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—NOS3—stomach cancer	8.79e-05	0.000448	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CCND1—stomach cancer	8.76e-05	0.000447	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—JUN—stomach cancer	8.74e-05	0.000446	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—ERBB2—stomach cancer	8.63e-05	0.00044	CbGpPWpGaD
Roflumilast—PDE4B—GPCR downstream signaling—PIK3CA—stomach cancer	8.53e-05	0.000435	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—SERPINE1—stomach cancer	8.51e-05	0.000434	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MMP9—stomach cancer	8.51e-05	0.000434	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—CDKN1A—stomach cancer	8.48e-05	0.000432	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—KRAS—stomach cancer	8.43e-05	0.00043	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—PIK3CA—stomach cancer	8.37e-05	0.000427	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK8—stomach cancer	8.27e-05	0.000422	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—ERBB2—stomach cancer	8.22e-05	0.000419	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—RHOA—stomach cancer	8.21e-05	0.000419	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CXCL8—stomach cancer	8.19e-05	0.000417	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—HRAS—stomach cancer	8.13e-05	0.000415	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—NOS3—stomach cancer	8.13e-05	0.000414	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDKN1B—stomach cancer	8e-05	0.000408	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CXCL8—stomach cancer	7.79e-05	0.000397	CbGpPWpGaD
Roflumilast—PDE4D—Signaling by GPCR—IL6—stomach cancer	7.79e-05	0.000397	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—PIK3CA—stomach cancer	7.74e-05	0.000395	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—HRAS—stomach cancer	7.74e-05	0.000395	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—VEGFA—stomach cancer	7.64e-05	0.000389	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CCND1—stomach cancer	7.63e-05	0.000389	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—JUN—stomach cancer	7.61e-05	0.000388	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDKN1B—stomach cancer	7.61e-05	0.000388	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—ERBB2—stomach cancer	7.6e-05	0.000388	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—STAT3—stomach cancer	7.56e-05	0.000386	CbGpPWpGaD
Roflumilast—PDE4A—Signaling by GPCR—IL6—stomach cancer	7.41e-05	0.000378	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MMP9—stomach cancer	7.41e-05	0.000377	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—CDKN1A—stomach cancer	7.38e-05	0.000376	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CCND1—stomach cancer	7.26e-05	0.00037	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—JUN—stomach cancer	7.24e-05	0.000369	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK3—stomach cancer	7.23e-05	0.000368	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CXCL8—stomach cancer	7.21e-05	0.000368	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK8—stomach cancer	7.2e-05	0.000367	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—HRAS—stomach cancer	7.16e-05	0.000365	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MMP9—stomach cancer	7.05e-05	0.000359	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDKN1B—stomach cancer	7.04e-05	0.000359	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MYC—stomach cancer	7.03e-05	0.000358	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—CDKN1A—stomach cancer	7.02e-05	0.000358	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—MAPK1—stomach cancer	6.88e-05	0.00035	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—EGFR—stomach cancer	6.87e-05	0.00035	CbGpPWpGaD
Roflumilast—PDE4B—Signaling by GPCR—IL6—stomach cancer	6.86e-05	0.000349	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK8—stomach cancer	6.86e-05	0.000349	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CCND1—stomach cancer	6.72e-05	0.000342	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—JUN—stomach cancer	6.7e-05	0.000342	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—VEGFA—stomach cancer	6.65e-05	0.000339	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—STAT3—stomach cancer	6.58e-05	0.000336	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MMP9—stomach cancer	6.52e-05	0.000332	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—CDKN1A—stomach cancer	6.5e-05	0.000331	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—KRAS—stomach cancer	6.49e-05	0.000331	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK8—stomach cancer	6.34e-05	0.000323	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—VEGFA—stomach cancer	6.33e-05	0.000323	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK3—stomach cancer	6.29e-05	0.000321	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—STAT3—stomach cancer	6.27e-05	0.000319	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MYC—stomach cancer	6.12e-05	0.000312	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK3—stomach cancer	5.99e-05	0.000305	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—MAPK1—stomach cancer	5.99e-05	0.000305	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—EGFR—stomach cancer	5.98e-05	0.000305	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—PIK3CA—stomach cancer	5.97e-05	0.000304	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—VEGFA—stomach cancer	5.86e-05	0.000299	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MYC—stomach cancer	5.82e-05	0.000297	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—STAT3—stomach cancer	5.8e-05	0.000296	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—TP53—stomach cancer	5.77e-05	0.000294	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—MAPK1—stomach cancer	5.7e-05	0.00029	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—EGFR—stomach cancer	5.7e-05	0.00029	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—KRAS—stomach cancer	5.65e-05	0.000288	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK3—stomach cancer	5.54e-05	0.000282	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—HRAS—stomach cancer	5.52e-05	0.000281	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MYC—stomach cancer	5.39e-05	0.000275	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—KRAS—stomach cancer	5.38e-05	0.000274	CbGpPWpGaD
Roflumilast—PDE4C—Signaling Pathways—IL6—stomach cancer	5.28e-05	0.000269	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—MAPK1—stomach cancer	5.27e-05	0.000269	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—EGFR—stomach cancer	5.27e-05	0.000269	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—PIK3CA—stomach cancer	5.19e-05	0.000265	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—TP53—stomach cancer	5.02e-05	0.000256	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—KRAS—stomach cancer	4.98e-05	0.000254	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—PIK3CA—stomach cancer	4.94e-05	0.000252	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—HRAS—stomach cancer	4.81e-05	0.000245	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—TP53—stomach cancer	4.78e-05	0.000244	CbGpPWpGaD
Roflumilast—PDE4D—Signaling Pathways—IL6—stomach cancer	4.6e-05	0.000234	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—PIK3CA—stomach cancer	4.57e-05	0.000233	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—HRAS—stomach cancer	4.57e-05	0.000233	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—TP53—stomach cancer	4.43e-05	0.000226	CbGpPWpGaD
Roflumilast—PDE4A—Signaling Pathways—IL6—stomach cancer	4.38e-05	0.000223	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—HRAS—stomach cancer	4.23e-05	0.000216	CbGpPWpGaD
Roflumilast—PDE4B—Signaling Pathways—IL6—stomach cancer	4.05e-05	0.000206	CbGpPWpGaD
